Cas:26946-54-3 N-(2-Chlorophenyl)benzenecarbohydrazonoylchloride manufacturer & supplier

Chemical Name:N-(2-Chlorophenyl)benzenecarbohydrazonoylchloride

CAS.NO:26946-54-3

Synonyms:benz<k>aceanthrylene;benzoyl chloride 2-chlorophenylhydrazone;Benz-<2-chlor-phenylhydrazid>-chlorid;Benzoylchlorid-2-chlorphenylhydrazin

Molecular Formula:C₁₃H₁₀Cl₂N₂

Molecular Weight:265.13800

HS Code:2928000090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:366.9ºC at 760 mmHg

Density:1.24g/cm3

Index of Refraction:1.598

PSA:24.39000

Exact Mass:264.02200

LogP:4.42550

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like benz&lt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzoylchlorid-2-chlorphenylhydrazin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,-chlorid Use and application,benz&lt technical grade,usp/ep/jp grade.

Related News: Roche’s second anti-tau antibody UCB0107, partnered with UCB, is also slated to enter deeper testing this year. Tau had appeared to have fresh promise as a rival of sorts to amyloid. Tau theory goes that neurofibrillary tangles that form inside cells clog up the brain, and clearing this can help Alzheimer’s patients. N-(2-Chlorophenyl)benzenecarbohydrazonoylchloride manufacturer Nearly all patients who got the vaccine developed antibodies designed to head off the spread of abnormal tau while leaving healthy tau proteins intact, Novak said. N-(2-Chlorophenyl)benzenecarbohydrazonoylchloride supplier The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA. N-(2-Chlorophenyl)benzenecarbohydrazonoylchloride vendor Nearly all patients who got the vaccine developed antibodies designed to head off the spread of abnormal tau while leaving healthy tau proteins intact, Novak said. N-(2-Chlorophenyl)benzenecarbohydrazonoylchloride factory Roche’s second anti-tau antibody UCB0107, partnered with UCB, is also slated to enter deeper testing this year. Tau had appeared to have fresh promise as a rival of sorts to amyloid. Tau theory goes that neurofibrillary tangles that form inside cells clog up the brain, and clearing this can help Alzheimer’s patients.